Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
FDA Accepts Drug Master File, Signifying a New Milestone for Touchlight's Enzymatic doggybone DNA Technology
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, today announced a […]
US FDA Accepts Supplemental New Drug Application for Jardiance® for Adults with Chronic Kidney Disease
The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) […]
Evaxion Receives FDA Fast-track Designation for Personalized Cancer Immunotherapy
Evaxion Biotech A/S, a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, today […]
Linnaeus Therapeutics Granted Orphan Drug Designation for LNS8801 for the Treatment of Patients with Metastatic Cutaneous Melanoma
Linnaeus Therapeutics, a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of […]
Strata Oncology Announces Addition of Gilead as Strata PATH Trial Collaborator
Strata Oncology, a next-generation precision oncology company enabling smarter and earlier cancer treatment, has today […]
FDA Accepts GMP Plasmid DMF of OBiO Technology
OBiO Technology, a gene and cell therapy-focused contract research organization (CRO) and contract development and […]
Medivir Partner Infex Therapeutics Receives FDA QIDP Designation
Medivir AB has announced that its partner Infex Therapeutics, a leading anti-infectives specialist, has been […]
Jnana Therapeutics Announces FDA Clearance of IND Application for JNT-517 for the Treatment of Phenylketonuria
Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug […]
Tempero Bio has Received FDA Clearance to Advance Clinical Development of TMP-301 for Treatment of Alcohol and Substance Use Disorders
Sosei Group Corporation, the world leader in G protein-coupled receptor (GPCR) focused structure-based drug design […]
U.S. FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors
Datar Cancer Genetics has announced that the US Food and Drug Administration (FDA) has granted […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more